Artificial Intelligence Systems for Diabetic Retinopathy Screening: Appraisal on the 3rd US FDA Approved Algorithms- AEYE-DS
Journal Title: Journal of Ophthalmology and Advance Research - Year 2023, Vol 4, Issue 2
Abstract
Artificial Intelligence (AI) has revolutionized the field of healthcare in recent years, and one of its most promising applications is on the interpretation of medical images [1]. In ophthalmology, the first success comes to the screening and diagnosis of Diabetic Retinopathy (DR) [2]. DR is a common complication of Diabetes Mellitus (DM) that affects the eyes, and early detection and treatment is crucial in preventing vision loss, especially over the working populations [3]. The use of AI in DR screening involves analyzing digital fundus images to detect any signs of DR, including microaneurysms, dot and blot haemorrhages, cotton-wool spots, venous beading, intraretinal microvascular anomalies [4]. Currently, there are 3 US FDA approved systems on DR screening, IDx-DR (Digital Diagnostics), EyeArt (Eyenuk, Inc) and AEYE-DS (AEYE Health, Inc) [5-7]. AI has several advantages over traditional screening methods, including usage by non-ophthalmologically trained medical personnel, accessible and stable performance over whatever time and place, increased speed of clinical workflow, these might potentially help to improve outcomes for patients with DM. In the era of rapidly advancing technology, the use of AI in ophthalmology is an exciting development that might transform our future practice [8]. In this appraisal, we focus on the 3rd US FDA approved AI algorithms for DR.
Authors and Affiliations
Vanessa, Ching Chi Lee, Sunny Chi Lik Au
Keywords
Related Articles
- EP ID EP718833
- DOI https://doi.org/10.46889/JOAR.2023.4202
- Views 46
- Downloads 0
A Study on Ocular Manifestations Seen in Patients with Cerebral Palsy
Background: Cerebral palsy is a multitude of neurological disorders due to abnormal development of brain or permanent insult to the brain tissue affecting the muscle tone, movement of limbs thus leading to motor abnorm...
Mercureid Gives New Opportunities for Treatment and Prevention of Complications Caused by COVID-19 in Patients with Ophthalmic Pathologies
The coming era of COVID-19 introduces critical challenges for researchers. Accordingly, new questions connected with the current state of people’s health arise, namely, what consequences will be for the patients who ha...
Qualifications for Retinitis Pigmentosa and Leber Congenital Amaurosis Patients for Adeno-Associated Viral Gene-Replacement Therapy Clinical Trials
Introduction: This study identifies Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) patients at an Inherited Retinal Disease (IRD) clinic that qualify for ongoing or FDA-approved Adeno-Associated Virus (AA...
Peculiarities of Ocular and Systemic Pathology in the Elderly
The pathology of the elderly is the direct result of the aging process, aggravated by the physical and mental involution that occurs with advancing age. Age-related eye changes are present, such as: presbyopia, decreased...
Glaucoma Diagnosis Using Multivariate Analysis of Optical Coherence Tomography Angiography Compared to Clinical and Structural Retinal Data
Purpose: To characterize the ability of ImageJ-derived measurements of Optical Coherence Tomography Angiography (OCTA) to diagnose healthy vs Primary Open-Angle Glaucoma (POAG) Eyes. Methods: This retrospective study...